Apollo Neuro
Wearable technology for stress, sleep & performance
- 1-20 employees
- B2C
- Retail
- Mental health
- Consumer Goods
- Wellbeing
- Consumer Appliances
- Daly City, CA
Jump to section
Company mission
To empower people to take control of their health and well-being, effortlessly.
Our take
The last few years has seen huge growth for the wellness industry, growing around 35% since 2019. Indeed, the wellness economy is expected to be worth as much as $9.8T by 2029. So, its no surprise a great deal of startups in the space are building mental health platforms, while consumer supplements are also on the rise.
Apollo Neuro is doing things a little differently, with its research-based wearable which uses touch therapy to reduce stress and anxiety, and improve sleep, energy, and focus. The company was spun out of the work of co-founder Dr. David Rabin at the University of Pittsburgh.
Considering that the wearable is patented and is the first of its kind to be backed by scientific research, alongside the company reporting its users gained over 140M minutes of extra sleep in 2025 alone, show that a bright future is certainly on the horizon for Apollo.
Kirsty
Company Specialist at Welcome to the Jungle
Funding (last 2 of 8 rounds)
Sep 2023
$9.8m
LATE VC
Mar 2022
$15m
SERIES A
Total funding: $43.2m
Leadership
Dr. David Rabin, MD
(Co-Founder & Chief Medical Officer)Neuroscientist and board-certified Psychiatrist. Former Physician & Research Scientist at the University of Pittsburgh Medical Center. Executive Director of the Board of Medicine, Chief Medical Advisor at SANCTUM Aspen and Senior Research Scientist at the Florida Institute for Human and Machine Cognition.
Kathryn Fantauzzi
(Co-Founder & CEO)Previously worked on the development and launch of a $20M tech commercialization accelerator through the NY State Energy Research & Development Authority (NYSERDA). Also led Green Jobs Green NY, a nationally-recognized revolving loan fund for investment in sustainability projects and economic development.